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The role of human ribosomal proteins in the maturation
of rRNA and ribosome production
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Department of Internal Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine,
St. Louis, Missouri 63110, USA
2

ABSTRACT
Production of ribosomes is a fundamental process that occurs in all dividing cells. It is a complex process consisting of the
coordinated synthesis and assembly of four ribosomal RNAs (rRNA) with about 80 ribosomal proteins (r-proteins) involving
more than 150 nonribosomal proteins and other factors. Diamond Blackfan anemia (DBA) is an inherited red cell aplasia caused
by mutations in one of several r-proteins. How defects in r-proteins, essential for proliferation in all cells, lead to a human
disease with a specific defect in red cell development is unknown. Here, we investigated the role of r-proteins in ribosome
biogenesis in order to find out whether those mutated in DBA have any similarities. We depleted HeLa cells using siRNA for
several individual r-proteins of the small (RPS6, RPS7, RPS15, RPS16, RPS17, RPS19, RPS24, RPS25, RPS28) or large subunit
(RPL5, RPL7, RPL11, RPL14, RPL26, RPL35a) and studied the effect on rRNA processing and ribosome production. Depleting
r-proteins in one of the subunits caused, with a few exceptions, a decrease in all r-proteins of the same subunit and a decrease
in the corresponding subunit, fully assembled ribosomes, and polysomes. R-protein depletion, with a few exceptions, led to the
accumulation of specific rRNA precursors, highlighting their individual roles in rRNA processing. Depletion of r-proteins
mutated in DBA always compromised ribosome biogenesis while affecting either subunit and disturbing rRNA processing at
different levels, indicating that the rate of ribosome production rather than a specific step in ribosome biogenesis is critical in
patients with DBA.
Keywords: Diamond Blackfan anemia; ribosome biogenesis; siRNA; ribosome profile

INTRODUCTION
The production of ribosomes, the sites of protein synthesis,
is a process of fundamental importance in cell biology. It
has been estimated that in a rapidly growing yeast cell,
the majority of transcription is devoted to ribosomal RNA
(rRNA) and about half of RNA polymerase II transcription
to ribosomal proteins (r-proteins) (Warner 1999). Tandem
arrays of ribosomal genes are transcribed by RNA polymerase I in the nucleolus and the transcripts are cleaved,
modified, and assembled with r-proteins to form the
mature 40S and 60S subunits of the mature ribosome.
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Ribosome production in the nucleolus and export to the
cytoplasm involve the coordinated synthesis of four rRNAs,
about 80 r-proteins, more than 150 other proteins, and
about 70 snoRNAs. The 60S subunit contains 28S, 5.8S,
and 5S RNAs, while the 40S subunit contains 18S RNA.
5S RNA is transcribed by RNA polymerase III and
imported into the nucleolus during ribosome maturation.
Most of our knowledge about ribosome biogenesis derives
from genetic studies in yeast and bacteria. While there is a
high level of conservation between the components of
ribosome biogenesis in yeast and mammalian cells, studies
of mammalian ribosome production are still in their
infancy.
Interest in mammalian ribosome biosynthesis has been
stimulated by the finding that the pathogenesis of a number
of inherited and acquired diseases involves mutations in
genes encoding components of the ribosome or proteins
involved in ribosome maturation, assembly, or export.
Diamond Blackfan anemia (DBA, OMIM#105650) is a rare
inherited bone marrow failure syndrome that affects mainly
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the terminal stages of red cell differentiation (OheneAbuakwa et al. 2005; Lipton 2006). DBA is caused by
mutations in one of several genetic loci, all of which code
for r-proteins in both the small and large ribosomal subunit
(Draptchinskaia et al. 1999; Willig et al. 1999; Gazda et al.
2006; Cmejla et al. 2007; Farrar et al. 2008; H. Gazda,
pers. comm.). A major shift in our perception of the role of
r-proteins came in 2000 when it was found that the catalytic molecule in ribosomes is rRNA and the r-proteins are
likely to be responsible for the correct folding of rRNA,
needed for accurate cleavage and processing, and for the
assembly of the ribosome (Steitz and Moore 2003). The precise role of the 80 or so r-proteins in ribosome biogenesis is
not fully understood, especially in mammals. In addition to
their role in ribosome biogenesis, extraribosomal functions
have been postulated for many of the r-proteins (Wool 1996).
DBA is usually diagnosed as a severe anemia in early
childhood caused by a defect in red cell maturation (red
cell aplasia). As well as failure of red cell development,
the disorder may be associated with a variety of congenital
abnormalities and a predisposition to malignancy (Lipton
2006). Mutations causing DBA have been found in RPS19
(accounting for 25% of cases) (Draptchinskaia et al. 1999;
Willig et al. 1999); RPS24 (2%) (Gazda et al. 2006); RPS17
(one case) (Cmejla et al. 2007); RPL35a (2%) (Farrar et al.
2008); and RPL5 and RPL11 (10% each) (H. Gazda, pers.
comm.). In all cases the inheritance is autosomal dominant;
haploinsufficiency for the r-protein is thought to be the
mechanism of disease (Gazda et al. 2004). However,
the mechanism whereby haploinsufficiency for one of several
r-proteins leads specifically to red cell aplasia while only
minimally affecting other tissues is unknown. Mice heterozygous for an Rps19 gene deletion develop normally with
no abnormalities in red cell development (Matsson et al.
2004, 2006). In contrast, cell culture studies using bone
marrow cells or peripheral blood hematopoietic progenitor
cells from patients with DBA show that the defect is
intrinsic to the red cell progenitors, which fail to complete
differentiation in response to erythropoietin (OheneAbuakwa et al. 2005). Depleting the amount of RPS19 in
human CD34+ primitive hematopoietic progenitors causes
a reduction in the proliferation of immature red cells (Ebert
et al. 2005; Flygare et al. 2005). It has recently been shown
that the depletion of RPS19 in human cell lines by siRNA
causes decreased ribosome synthesis with accumulation
of some specific rRNA precursors (Choesmel et al. 2007;
Flygare et al. 2007; Idol et al. 2007). The same precursors
were found to accumulate to some extent in patients’
fibroblasts, lymphocyte cell lines, and, in one case, in
primary cells from bone marrow (Flygare et al. 2007).
Similarly, depletion of RPS24 causes decreased rRNA
synthesis due to failure of an earlier step in 18S rRNA
processing (Choesmel et al. 2008). Since the only known
genetic cause of DBA is mutations in genes coding for
r-proteins, we were interested to test whether the possible

molecular mechanism would be a specific defect in the
synthesis of ribosomes shared by the r-proteins affected in
DBA.
To investigate this hypothesis and to gain insight into
the molecular mechanism responsible for disease, we depleted HeLa cells for the mRNA coding for a selection of
r-proteins, including several known to be involved in DBA
pathogenesis. We found that depletion of r-proteins
involved in the pathogenesis of DBA may affect either
subunit, but always was associated with a decrease in the
production of ribosomes. We further found that depletion
of any r-proteins involved in the pathogenesis of DBA also
decreased the amount of all r-proteins from the same
subunit, and caused a decreased production of the corresponding subunit. The alterations in rRNA processing
varied amongst the various DBA-associated r-proteins
and did not correlate with disease association. We therefore
conclude that any of the r-proteins, when mutated, compromise ribosome biogenesis, is a potential candidate for
DBA, and that the common factor is the decreased production of ribosomes rather than a specific step in
ribosome biogenesis or the accumulation of a specific
rRNA or ribosome subunit precursor.
RESULTS
In order to investigate whether there are common features
in the function of r-proteins mutated in DBA, we investigated the role of 15 r-proteins in ribosome biosynthesis and
rRNA processing, including six r-proteins that are currently
known to be affected in DBA. At the time the study was
initiated, only r-proteins of the small subunit RPS19
(Draptchinskaia et al. 1999), RPS24 (Gazda et al. 2006),
and RPS17 (Cmejla et al. 2007) were known to be mutated in DBA. During the course of the study, the number
of r-proteins responsible for DBA increased, including proteins belonging to the large r-subunit, RPL35a (Farrar et al.
2008), and RPL5 and RPL11 (H. Gazda, pers. comm.).
Depletion of r-protein mRNAs in HeLa cells
using siRNA
We and others have previously reported on the effect of
r-protein RPS19 depletion on ribosome biosynthesis and
rRNA processing. Here, we used a similar approach
depleting individual r-proteins in growing HeLa cells using
siRNA. In addition to the proteins RPS17, RPS19, RPS24,
RPL5, RPL11, and RPL35a known to be associated with
DBA, we also studied the depletion of RPS6, RPS7, RPS15,
RPS16, RPS25, RPS28, RPL7, RPL14, and RPL26. To date,
these r-proteins have not been associated with DBA, but
their involvement is not ruled out, as the causative
mutation has not been found in about half of the known
DBA patients. The efficiency of r-protein depletion was
assessed by Western blotting using either commercially
www.rnajournal.org
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available or in-house antibodies and by Northern analysis
using cDNA probes.
Figure 1 is an example of the data showing the depletion
of mRNA for the r-proteins in our study. In all cases, the
siRNA reduces the abundance of the mRNA to almost
undetectable levels. The percentage knockdowns shown in
Figure 1 are those from one typical experiment obtained
from phosphorimaging of Northern blots. Notably, the
target mRNA was the only one that was decreased in
abundance. No evidence for reduction in one mRNA
causing consistent and significant reduction in any of the
others was found.
Depletion of r-proteins causes decreased abundance
of other r-proteins belonging to the same
ribosomal subunit
We next examined the effect of the mRNA knockdown on
the steady-state level of r-proteins. Protein was extracted
from the cells 72 h after the cells had been transfected with
the siRNAs, and r-proteins were examined by Western
blotting (Fig. 2). For this we generated peptide antibodies
for RPS7, RPS12, RPS15, RPS24, RPS25, and RPS28. We
have previously reported the generation of peptide antibodies against RPS19. Antibodies against RPS6, RPS16,

RPL7, and RPL26 were from commercial sources. Western
analysis showed that the steady-state level of the siRNA
targeted r-protein was decreased by 30%–60% (Fig. 2). In
several experiments, there was considerable variation in the
level of protein knockdown achieved. The knockdown of
one of the r-proteins always resulted in a decrease of the
steady-state levels of the other r-proteins belonging to the
same ribosomal subunit (Fig. 2). The exception to this was
RPS25. When RPS25 mRNA was reduced in abundance to
almost zero, RPS6, RPS12, RPS16, RPS19, and RPS24 did
not significantly change in abundance. Using an antibody
to RPS25 shows that cells treated with siRNA to RPS25
were indeed depleted for RPS25 and that no reduction in
the steady-state level of any of the other r-protein of the
small subunit (RPS) proteins was apparent. For r-proteins
belonging to the large ribosomal subunit, RPL7, RPL14,
RPL26, and RPL35a (RPLs), we used antibodies against
RPL7 and RPL26. Figure 2 shows that, as expected, there
was a reduction in the steady-state levels of RPL7 and
RPL26 when the level of their mRNAs was reduced. In
keeping with our results from the RPS knockdowns, the
levels of RPL7 and RPL26 proteins were reduced to a
similar extent when RPL5, RPL7, RPL11, RPL14, or
RPL35a were knocked down. Interestingly, though RPS19
was unaffected by depletion of RPL5, RPL7, RPL11, RPL14,
or RPL35a, depletion of RPL26 caused
an approximate 30% reduction in
RPS19 level. Depletion of the RPS
proteins had no effect on the levels of
RPL26.
Depletion of r-proteins causes
decreased production of mature
ribosomes and functionally
active polysomes

FIGURE 1. Efficient depletion of r-protein mRNA in HeLa using siRNA. Cells were
transfected with scrambled negative control siRNA or siRNAs targeting the RPS6, RPS7,
RPS15, RPS16, RPS17, RPS19, RPS24, RPS25, RPS28, RPL7, RPL14, RL26, or RPL35a mRNAs.
After 72 h, total RNA was extracted and subjected to Northern blotting analysis. Membranes
were hybridized with cDNA probes for one of each r-protein; mouse b-actin was used as a
loading control. The percentage decrease in the targeted mRNA by the siRNA is indicated
(right side for each panel). (A) Efficient depletion of targeted small subunit (RPS) mRNAs.
A single experiment where equivalent amounts of RNAs were analyzed on three separate blots.
Note RNA from the RPS6 depletion experiment is overloaded in this experiment. (B) Efficient
depletion of targeted large subunit (RPL) mRNAs.
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We next investigated the effect of the
depletion of individual r-proteins on
the ribosome profile in the HeLa cells
72 h after siRNA treatment. HeLa cells
that were mock transfected showed a
classical profile of ribosomes and polysomes, with the 40S and 60S ribosomal
subunits and a large 80S peak representing the mature assembled ribosome
(monosome). Depletion of any of the
RPSs caused a reduction in the amount
of free 40S subunits, a great reduction
in the amount of mature 80S ribosomes,
and an increase in the amount of free
60S subunits (Fig. 3). The exception was
again RPS25. Here, the ribosome profile
showed an intermediate phenotype with
a reduction in the amount of 80S ribosomes and an increase in the amount of
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RPL knockdowns, there appears to be a decrease in the
overall number of polysomes.
Depletion of r-proteins blocks rRNA processing
at specific steps
The r-proteins not only serve as a scaffold for the rRNA and
ensure the correct structure of the ribosome, but are also
involved in the maturation of the rRNA precursors. Having
found that depleting any r-protein decreases the production of one ribosomal subunit and, consequently, production of mature ribosomes, we were interested to know
the effect of each depletion on pre-rRNA processing. Since
ribosome biogenesis involves a characteristic series of rRNA
processing events, we can investigate the extent, and at
which level, pre-rRNA processing is affected by the depletion of individual r-proteins. RNA was extracted from
HeLa cells 72 h after the cells had been transfected with
the various siRNAs. The RNA was subjected to Northern
blotting using a series of probes from within the rRNA
FIGURE 2. Knocking down ribosomal proteins decreases the levels of
other ribosomal proteins of the same subunit. Western blot analysis
of r-protein levels after siRNA treatment. Total cellular protein was
extracted 72 h after treatment with siRNA specific to each target or a
scrambled sequence. (A) Western blotting was performed to examine
the levels of RPS6, RPS12, RPS16, RPS19, RPS24, RPS25, RPL26;
GAPDH was used as a loading control. Knocking down all RPS proteins analyzed decreased the levels of other RPS proteins, with the exception of RPS25. RPS25 protein levels were decreased by treatment
with siRNA against RPS25, although the levels of the other r-proteins
of the small subunit examined did not change. The levels of RPL
proteins did not decrease. (B) Western blot analysis of RPL7, RPL26,
and RPS19 protein levels after depletion of RPL proteins; GAPDH was
used as a loading control. Knocking down all RPL proteins analyzed
decreased the levels of other RPL proteins. The levels of r-proteins of
the small subunit did not decrease, except in the RPL26 knockdown
where a slight reduction of RPS19 levels was observed.

60S subunits, but no significant changes in the amount of
the 40S subunit. In the polysome region of the profiles, we
note a variation in the extent to which polysomes are
decreased with a trend toward a decrease in the relative
number of large polysomes, perhaps reflecting a decrease in
the number of initiations caused by the deficiency in the
number of 40S subunits. A somewhat different pattern was
seen when RPLs were depleted (Fig. 3). In the case of RPL5,
RPL7, RPL11, RPL14, RPL26, and RPL35a depletion
compared with the normal ribosome profile, the amount
of the 60S subunit was greatly reduced, as was the peak
representing the levels of 80S ribosomes. There was a
concomitant increase in the amount of free 40S subunit,
although for the RPL26 depletion the free 40S subunit did
not show this increase. In these profiles, the 80S and
polysome peaks are split, an appearance characteristic of
‘‘halfmers,’’ which are monosomes and polysomes to which
an isolated 40S subunit is bound (Helser et al. 1981). In the

FIGURE 3. Depletion of r-proteins impairs the synthesis of new
ribosomes. After 72 h of treatment with siRNA, cells were treated with
cycloheximide, lysed, and the cytoplasmic fraction was layered over
10%–45% sucrose gradients. Mock or scramble treated cells show a
typical profile of free 40S, free 60S, 80S, and polysomes. Cells depleted
for RPS6, RPS7, RPS15, RPS16, RPS17, RPS19, RPS24, and RPS28
have significantly decreased levels of free 40S and 80S, with a dramatic
increase in free 60S. The polysome levels are decreased. RPS25
depleted cells show an intermediate phenotype, with a slight decrease
in free 40S, an increase in free 60S, and partial decrease in 80S.
Depleting cells of RPL5, RPL7, RPL11, RPL14, and RPL35a show an
increase in free 40S subunits, a substantial decrease in free 60S
subunits, and a decrease in the 80S. Polysome profiles also demonstrate the presence of halfmers and a decrease in polysomes,
particularly the larger polysomes. Depletion of RPL26 also decreased
the free 60S subunit and the 80S and produced halfmer polysomes,
although the free 40S levels did not increase as dramatically as was
seen with other RPL knockdowns.
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locus. The location of the probes and
the rRNA processing pathway as it is
thought to occur in HeLa cells (Hadjiolova
et al. 1993) is schematically shown
in Figure 4A. Figure 4B shows the
effects on pre-rRNA processing of the
depletion of r-proteins of the small
subunit. Depletion of RPSs affected
the formation of the mature 18S rRNA,
while the formation of the mature 28S
and 5.8S RNA was not significantly
affected (Fig. 5; data not shown). The
defects in rRNA processing detected by
Northern blotting after the depletion of
individual r-proteins of the small subunit fell into three district categories.
The most frequently observed defect in
pre-rRNA processing, seen after depleting RPS6, RPS7, RPS16, RPS24, and
RPS28, was characterized by the decrease of the 41S rRNA precursor and
an accumulation of a 30S rRNA processing intermediate, and a decrease in
the 21S and 18SE precursors. This
implies that the respective r-proteins
are essential for the processing at the
59-ETS, which leads to the decrease in
the 41S, the accumulation of the 30S
precursor, and a decrease of the 21S
r-RNA and 18S-E precursors. For
RPS24, similar findings were reported
by Choesmel et al. (2008). A different
pre-rRNA processing defect was observed for RPS17 and RPS19 depletion,
which caused accumulation of the 21S
and 20S precursors, implying that these
two r-proteins are required for a later
step in pre-rRNA processing during
which the 21S molecule is processed to
form the 18S-E nuclear precursor. The
third defect is shown after the depletion
of RPS15 and also after depletion of
RPS25. Here, all the rRNA precursors
are present at levels similar to those in
untreated cells or cells treated with the
scrambled control siRNA, and 18S-E is
exported into the cytoplasm in both
cases. Interestingly, results from the
ribosome profiles obtained from
RPS15-depleted cells show that the production of 40S subunits is defective in
these cells, whereas in RPS25-depleted
cells the production of the 40S subunit
is only impaired, leading us to conclude
that RPS15 may play a role late in
1922

RNA, Vol. 14, No. 9

FIGURE 4. Ribosomal proteins of the small subunit control distinct rRNA processing steps
important for the maturation of the 18S rRNA. (A) Schematic diagram of pre-rRNA
processing pathways in HeLa cells. (Inset) Structure of the primary 47S rRNA transcript
containing two external transcriber spacers at its 59 and 39 ends (59ETS and 39ETS,
respectively), as well two internal transcriber spacers (ITS1 and ITS2). (Arrows) Position of
major processing sites (0–4). The 47S pre-rRNA is processed through intermediate precursors
designated according to their relative sedimentation coefficients (S) to mature 18S, 28S, and
5.8S rRNAs. In HeLa cells, 45S pre-rRNA can be processed by two alternative pathways.
Pathway A is initiated with the removal of 59-ETS by cleavage at site 1, while pathway B starts
with cleavage in ITS1, probably at site 2 (Hadjiolova et al. 1993; Rouquette et al. 2005; Idol
et al. 2007). The sequence locations of the probes used in Northern blot analysis are shown as a
line above the primary transcript scheme (bottom). (B) Northern hybridization of total RNA
from HeLa cells after depletion of r-proteins of the small subunit. Cells were transfected with
scrambled negative control siRNA or siRNAs targeting RPS6, RPS7, RPS15, RPS16, RPS17,
RPS19, RPS24, RPS25, or RPS28 mRNAs. After 72 h, total RNA was extracted and subjected to
Northern blotting analysis for pre-rRNA species. Membranes were hybridized with probes for
the 59 end of ITS1 (probe i, upper panel), 59 ends of ITS2 (probe f, lower panel), or b-actin.
(Left panel) Short exposure, (right panel) long exposure. Depletion of r-proteins of the small
subunit block rRNA processing at specific steps. The sizes of pre-rRNA species are indicated
between the left and right panels. (C) Northern hybridization of total (T), nuclear (N), and
cytoplasmic (C) rRNA isolated from HeLa cells after depletion of r-proteins of RPS15 and
RPS25. Cells were transfected with scrambled negative control siRNA or siRNAs targeting
RPS15 and RPS25 mRNAs. Membranes were hybridized with probes for the 59 end of ITS1
(probe i).

Downloaded from rnajournal.cshlp.org on September 6, 2015 - Published by Cold Spring Harbor Laboratory Press

Ribosomal proteins in ribosome biogenesis

mature 5.8S rRNA, whereas in RPL5
and RPL11 depletions the 12S rRNA
precursor accumulated (Fig. 6A). Metabolic labeling studies (Fig. 6B) showed
all six RPL knockdowns led to greatly
decreased 28S synthesis. Interestingly,
depletion of RPL26 also led to significantly decreased levels of the 21S and
18S-E rRNA, whereas that of RPL35a
led to slightly decreased levels of the 30S
and 21S rRNA precursors as shown by
Northern blotting (Fig. 6A). RPL26
depletion led to lower and slower production of 18S RNA (Fig. 6B). These
data indicate that these two RPLs also
affect the processing and cleavage of
the 45S pre-RNA at the 59-ETS (site 01
and 1) and ITS1 (site 2 and E).
DISCUSSION
Ribosomal protein genes have been
found to be the genes mutated in
patients with DBA, a rare inherited
form of red cell aplasia. So far,
three genes encoding RPSs: RPS19,
(Draptchinskaia et al. 1999; Willig et al.
1999), RPS17 (Cmejla et al. 2007), and
FIGURE 5. Impaired 18S rRNA synthesis in HeLa cells depleted of r-proteins of the small RPS24 (Gazda et al. 2006), and three
subunit. Cells were transfected with scrambled negative control siRNA or siRNAs targeting genes encoding RPLs: RPL5, RPL11
RPS6, RPS7, RPS15, RPS16, RPS17, RPS19, RPS24, RPS25, or RPS28 mRNAs. After 72 h, cells (H. Gazda, pers. comm.), and RPL35a
were pulsed with L-[methyl3H] methionine and then chased at 0, 30, 60, and 120 min. Total
(Farrar et al. 2008) have been found to
rRNA was extracted after labeling and analyzed by fluorography.
be mutated. In about one-half of the
patients, these are de novo mutations
occurring for the first time in the
ribosome biogenesis involving the final stages of maturaaffected individual, whereas in about one-half of patients
tion in the cytoplasm or interaction with the large subunit,
the mutations are inherited. Mutations include gene
whereas RPS25 is not essential for 40S subunit production.
deletions and frameshift mutations, suggesting that hapMetabolic labeling of cells with 3H-methylmethionine after
loinsufficency for the r-protein is the cause of the domidepletion of r-proteins of the small subunit similarly
nantly inherited disease (Gazda et al. 2004). The number of
DBA families with mutations in the genes varies, with
confirmed the decrease in the production of the mature
RPS19 accounting for one-fourth of families and RPL5 and
18S rRNA, while 28S rRNA was not affected. This was the
RPL11 each accounting for z10% of patients; whereas
case in all knockdown cells with the exception of RPS15
and RPS25 depleted cells, which seemed to synthesize both
RPS24, RPS17, and RPL35a only account for a small
the 18S and 28S rRNA and all precursors at a level and rate
number of patients with DBA (Cmejla et al. 2007; Farrar
that were indistinguishable from normal or mock transet al. 2008; H. Gazda, pers. comm.). For more than half of
fected cells (Fig. 5).
the patients with DBA the mutation has not yet been
Northern blotting studies with knockdowns of RPLs
identified, and not all r-proteins have been screened for
disease causing mutations. Here, we examined whether the
(Fig. 6A) showed that depletion of all six RPLs tested,
r-proteins affected in DBA share a common pathway
comprising RPL7, RPL14, RPL26, RPL35a, RPL5, and
in ribosome biogenesis and/or pre-RNA processing that
RPL11, led to reduced levels of the mature 28S rRNA.
RPL7, RPL14, and to a lesser extent RPL26 depletion
would explain why a defect that potentially affects all
showed an accumulation of the 45S and 41S early precursor
dividing cells manifests itself as a disease of such exquisite
RNAs. Cells depleted for RPL7, RPL14, RPL26, and RPL35a
tissue and lineage specificity. Interestingly, depletion of the
also had reduced levels of the 12S precursor rRNA and the
affected r-proteins in HeLa cells using siRNA showed that
www.rnajournal.org
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other r-proteins. Furthermore, our
results demonstrated that the depletion
of r-proteins associated with DBA could
affect the biosynthesis of either the large
or small ribosomal subunit. Finally, we
found that pre-RNA cleavage was
impaired at various steps of rRNA
processing, leading to the accumulation
of different rRNA precursors. Interestingly, RPS19, RPL5, and RPL11, which
account for almost 35% of cases of
DBA, show defects in late nucleolar
maturation of the pre-40S and pre-60S
ribosomal particles.
With the exception of RPS25 and
RPS15, depletion of RPSs always led to
decreased levels of mature 18S rRNA,
decreased levels of the small 40S ribosomal subunit, and decreased levels of
mature 80S ribosomes. RPS15 did not
visibly affect rRNA processing, export of
the 18S-E RNA precursor, or the accumulation of the mature 18S RNA in
metabolic labeling experiments. However, the levels of 40S ribosomal subunits and 80S ribosomes were decreased,
indicating that RPS15 is essential for a
late maturation step of the 40S subunit.
In contrast, RPS25 seemed to have no
effect on rRNA processing, 18S-E export, or mature 18S rRNA accumulation, and was not essential for 40S and
80S ribosome biosynthesis, though formation of small subunits was reduced in
its absence. In all of these cases, impairment of the formation of the small
FIGURE 6. Ribosomal proteins of the large subunit control distinct rRNA processing steps, in
particular, those important for the maturation of the 28S rRNA and 5.8S rRNA. (A) Northern ribosome subunit did not affect the
hybridization of total RNA from HeLa cells after depletion of r-proteins of the large subunit. maturation of the 28S and 5.8S rRNA
Cells were transfected with scrambled negative control siRNA or siRNAs targeting RPL5, RPL7, and was associated with excess producRPL11, RPL14, RPL26, or RPL35a mRNAs. After 72 h, total RNA was extracted and subjected tion of the 60S large subunit.
to Northern blotting analysis for pre-rRNA species. Membranes were hybridized with probes
Ribosome biogenesis has been studfor the 59 end of ITS1 (probe i, upper panel) and 59 end of ITS2 (probe f, lower panel). PrerRNA products after hybridization with probe i (upper panel) and probe f (lower panel). (Left ied extensively in yeast. Several recent
panel) Short exposure, (right panel) long exposure. The sizes of pre-rRNA species are indicated studies have documented the role in ribobetween the left and right panels. This short run is shown to emphasize the characteristic some biogenesis of specific r-proteins
difference in 5.8S and 12S accumulation. (B) Analysis of the rRNA synthesis of 18S and 28S in
HeLa cells depleted of r-proteins of the large subunit by pulse-chase analysis with L- by depleting proteins using the power
[methyl3H] methionine labeling. Cells were transfected with scrambled negative control and elegance of yeast genetics (van
siRNA or siRNAs targeting RPL5, RPL7, RPL11, RPL14, RL26, or RPL35a mRNAs. After 72 h, Beekvelt et al. 2001; Leger-Silvestre
cells were pulsed with L-[methyl3H] methionine and then chased at 0, 30, 60, and 120 min.
et al. 2004, 2005; West et al. 2005;
Total rRNA was extracted after labeling and analyzed by fluorography.
Ferreira-Cerca et al. 2007; Rosado
et al. 2007). In both human and yeast,
RPS6, RPS16, and RPS24 depletion all
the only shared feature was that their depletion impaired
impair the processing of the 59 ETS, leading to the
the production of ribosomes, as assayed by examination
accumulation of an early precursor and decrease of the
of the ribosome profile on sucrose gradients, a character20S (yeast) 21S (human) rRNA molecule that is a precursor
istic we found to be shared with most, although not all,
to 18S rRNA. Similarly in both yeast and human, RPS19
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depletion leads to the accumulation of the 20S/21S rRNA
species, which is not processed further. Finally, in both
yeast and humans, RPS25 was not essential for ribosome
biosynthesis. However, we also identified distinct differences in the role of r-proteins in humans and yeast. In
contrast to yeast, in HeLa cells the ribosome profile was
altered after the depletion of RPS25 (see Fig. 3), suggesting
that the depletion of RPS25 allows the assembly of the 40S
subunit but impairs its association with the 60S subunit to
form the mature 80S ribosome or that the 80S ribosome is
unstable and is degraded. Furthermore, we found that
RPS15 depletion in human cell lines did not visibly impair
the processing of the rRNA, and that the 18S-E rRNA
precursor was exported into the cytoplasm as in mock
transfected cells or cells transfected with a scrambled
siRNA. However, the levels of 40S subunit and 80S mature
ribosomes were greatly reduced, suggesting that in humans
RPS15 is essential for the final cytoplasmic maturation and
assembly of the 40S subunit. In contrast, in yeast, depletion
of RPS15 leads to the accumulation of the 20S in the
nucleus, suggesting that RPS15 in yeast is essential for
export from the nucleus (Leger-Silvestre et al. 2004).
Finally, in HeLa cells, the depletion of RPS7 and RPS28
led to the accumulation of the early 30S rRNA precursor,
whereas in yeast, RPS7 and RPS28 affect the cytoplasmic
maturation of the 18S rRNA and terminal assembly of the
40S subunit. The defect in HeLa cells was assessed for at
least two independent siRNAs for each r-protein, indicating
that off-target effects were unlikely to account for the
differences observed. RPS17 depletion was not analyzed in
yeast. Further analysis will show whether these are real
differences in the yeast and human r-proteins and when in
evolution these proteins might have adopted a different
role in ribosome biogenesis.
Depletion of RPLs similarly primarily affected production of the mature 28S and 5.8S rRNA, the assembly of the
60S large ribosomal subunit, the mature 80S ribosome, and
led to the production of ‘‘halfmers,’’ due to the binding of
a 40S subunit to a mRNA without a 60S subunit. The
exception was the depletion of RPL26 that impaired both
the production of the mature 18S and 28S rRNA with a
reduction of both the 40S and 60S subunits, a reduction of
the 80S mature ribosome, and the generation of halfmers.
RPLs associated with DBA showed defects in either early or
late processing of the 28S and 5.8S rRNA, whereas the most
frequent forms of RPL mutations in DBA, RPL5, and
RPL11 affected the late steps in 28S and 5.8S maturation
occurring in the nucleolus. In contrast to RPSs, RPLs have
not been studied in a systematic manner in yeast; thus, a
comparison of the role of RPLs in ribosome biogenesis in
yeast and humans is not possible. Interestingly, RPL5 and
RPL11 share two other properties as well as their connection with DBA. Both have been implicated in negatively
regulating MDM2, a nucleolar protein that causes rapid
turnover of the oncoprotein p53 (Marechal et al. 1994;

Lohrum et al. 2003; Zhang et al. 2003). Moreover, both are
associated, at least in yeast, with 5S rRNA at an early stage
in ribosome biogenesis (Zhang et al. 2007).
One of the most interesting observations of our study is
that depleting a cell of a r-protein leads not only to a
decrease in the abundance of that protein as expected
but also to a concomitant decrease in the abundance of all
proteins from the same subunit. The most likely explanation for this observation is that the lack of one r-protein
prevents formation of a stable subunit, and other proteins
of that subunit with no structure to be incorporated into
are degraded. This explanation is compatible with early
results that showed excess ribosomal proteins, which are
not assembled into ribosomes, are rapidly degraded
(Warner 1977, 1979). This point has been reinforced by a
recent study showing that r-proteins are synthesized at rates
much higher than required for ribosome biogenesis, and
that excess proteins not incorporated into ribosomes are
rapidly degraded in the nucleoplasm (Lam et al. 2007). As
pointed out by Lam et al., this suggests a simple way for
the cell to solve the problem of coordinated synthesis of
r-proteins for ribosome production; i.e., they are simply
made in vast excess, and those not needed are degraded. In
the experiments presented here, when one protein becomes
limiting there is a rapid decrease in the other proteins of
that subunit. We observe this concerted decrease in
proteins of one subunit for all the knockdowns we have
carried out except for that of RPS25. Alternatively, when
one r-protein is under-produced, there may be some
assembly of other proteins into nascent subunits followed
by partial disassembly and turnover in the absence of
stoichiometric amounts of ribosomal components (Moritz
et al. 1990). This scheme may be more compatible with the
decrease in r-proteins and accumulation of rRNA precursors that we observe.
To what extent are our observations relevant to the
pathogenesis of DBA? At first glance there is a conundrum
since, if r-proteins are made in vast excess over requirements, then reducing the production of an r-protein by
50% as happens in DBA should not have a drastic effect.
We must therefore hypothesize that in developing red cells,
and possibly in cells of other tissues affected in DBA, there
is a requirement for maximal ribosome synthesis at a time
when DNA transcription is turned off as part of erythroid
maturation or in a key developmental stage elsewhere.
Erythroid precursors in response to erythropoietin do
indeed have a very high rate of ribosome production in
order to undergo the final red cell divisions and to be able
to produce the massive amounts of globin needed in the
mature circulating red cell (Rifkind et al. 1964; Flygare and
Karlsson 2007). If the rate of ribosome production required
was more than half of the maximum rate governed by
production of r-proteins, then haploinsufficiency for any
r-protein would slow ribosome production. In red cell
maturation, this may lead to the cell cycle arrest or cell
www.rnajournal.org
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death that is the hallmark of DBA. That some r-proteins
may be limiting such that a 50% reduction in quantity may
affect ribosome production in red cells, whereas for others
a reduction of 50% may not be limiting, or may also be
limiting in other tissues to the extent that it would interfere
with embryogenesis, might explain why mutations in
certain r-proteins account more frequently for DBA than
others (Ellis and Massey 2006). There are alternative
schemes that may underlie DBA pathogenesis. It is possible
that certain cell types such as the developing red cell may be
more sensitive to an imbalance in ribosome subunit production, and this may be more crucial in cells producing
ribosomes at a high rate. In our HeLa cell model,
the overproduction/degradation mechanism ensures that
r-proteins not incorporated into ribosome subunits do not
accumulate, but it is not clear whether this surveillance
mechanism is present in the maturing red cell. Furthermore, there does not appear to be a mechanism for
ensuring that large or small subunits do not accumulate
in the absence of the other subunit.
In summary, our results support the notion that a failure
in the production of ribosomes is the factor that triggers
the process leading to the red cell aplasia characteristic of
DBA. Presumably, any r-protein produced in limiting quantities and whose haploinsufficiency is not lethal in the embryo would be a candidate. Whether the crude number of
ribosomes or the disruption of the nucleolar structure
causing nucleolar stress and the activation of p53 are
keys to pathogenesis in DBA is subject to our future
investigations.
MATERIALS AND METHODS
Cell culture
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium
containing 15% fetal bovine serum, antibiotics (100 mg of
penicillin and 50 mg of streptomycin sulfate/mL), and 2 mM
glutamine at 37°C, 5% CO2.

RNA preparation
Total RNA was extracted using Trizol (Invitrogen) following the
manufacturer’s instructions. Nuclear and cytoplasmic fractions
were prepared using Cell fractionation buffer (Ambion), and then
nuclear or cytoplasmic RNA was extracted from each fraction with
Trizol.

Oligonucleotides
The oligonucleotide sequences complementary to the known
human rDNA used in this paper were:
(Probe i) 20-ITS1: 59-CCTCGCCCTCCGGGCTCCGTTAATTGA
TC-39 (Rouquette et al. 2005); and
(Probe f) 15-ITS2: 59-CGCACCCCGAGGAGCCCGGAGGCACC
CCCGG-39 (Hadjiolova et al. 1993).
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Complementary DNA was synthesized using SuperScript III
reverse transcriptase (Invitrogen) following the manufacturer’s
instructions. The following primers were used for PCR:
RPS6: 59-ATGAAGCTGAACATCTCCTTC-39 and 59-TTTCTGA
CTGGATTCAGACTTAG-39;
RPS7: 59-ATGTTCAGTTCGAGCGCC-39 and 59-CAATTGAAAC
TCTGGGAA-39;
RPS15: 59-ATGGCAGAAGTAGAGCAGAAG-39 and 59-CTTGAG
AGGGATGAAGCG-39;
RPS16: 59-ATGCCGTCCAAGGGCCCGCTGCAG-39 and 59-TCG
GTAGGATTTCTGGTAGCG-39;
RPS17: 59-ATGGGCCGCGTTCGCACCAAA-39 and 59-TCAAAC
AGGTCCCCGAGGCGT-39;
RPS19: 59-ATGCCTGGAGTTACTGTAAAA-39 and 59-CTAATGC
TTCTTGTTGGCAGC-39;
RPS24: 59-ATGAACGACACCGTAACT-39 and 59-CTCCTTCGG
CTTTTTGCC-39
RPS25: 59-ATGCCGCCTAAGGACGAC-39 and 59-TCATGCATC
TTCACCAGC-39;
RPS28: 59-ATGGACACCAGCCGTGTG-39 and 59-TCAGCGCAA
CCTCCGGGCTT-39;
RPL7: 59-ATGGAGGGTGTAGAAGAG-39 and 59-GTTCATTCTT
CTAATAAGCCTG-39;
RPL14: 59-ATGGTGTTCAGGCGCTTC-39 and 59-TGCTTTCTTG
CCAGATGC-39;
RPL26: 59-ATGAAGTTTAATCCCTTTGTGAXTTCCG-39 and 59TTCCTGCATCTTCTCAATGGT-39; and
RPL35a: 59-ATGTCTGGAAGGCTGTGGTCC-39 and 59AATCCT
TGAGGGGTACAGCAT-39.
The first strand cDNA was synthesized by RT-PCR from
total RNA using the SuperScript First-Strand Synthesis System (Invitrogen). After synthesis, target cDNA was amplified with
specific primers by PCR with Platinum Taq DNA polymerase
high fidelity (Invitrogen) for 35 cycles under the following
conditions: 15 sec, 94°C; 30 sec, 55°C; and 60 sec, 68°C. PCR
products were resolved by electrophoresis on 1% agarose.

rRNA analysis
Pre-rRNA analysis by Northern blotting was adapted from
Hadjiolova et al. (1993) using synthetic oligonucleotide DNA
and cDNA as probes. RNA (10 mg) was electrophoresed in 1.25%
(w/v) agarose–formaldehyde gels and blotted to Hybond-N+
membranes (GE Healthcare) overnight. Oligonucleotides were
end-labeled with [g-32P]ATP and T4 polynucleotide kinase
(Fisher), and cDNA probes were labeled with [32P]dCTP using
the Rediprime II random prime labeling system (Amersham
Biosciences).
Membranes were hybridized overnight in hybridization
buffer (0.75 M NaCl, 0.075 M Na citrate pH 7.0, 13 Denhardt’s
solution, 150 mg/mL tRNA) and 1% SDS (when oligonucleotide
probes were used), or 0.25 M Na/phosphate buffer, 1.0 g/L
BSA, and 7% SDS (when cDNA probes were used). Temperature
of hybridization was 55°C (probe i) and 65°C (probe f and
cDNA probes for all different RPSs, RPLs, and b-actin). Washing
conditions included 33 SSC, 0.1% SDS for 15 min; 23 SSC, 0.1%
SDS for 30 min; and 0.23 SSC, 0.1% SDS for 30 min at 55°C or
65°C (for oligonucleotide probes i and f, respectively), or 33 SSC,
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0.3% SDS for 15 min; 23 SSC, 0.3% SDS for 30 min; and 0.23
SSC, 0.3% SDS for 45 min at 65°C (for cDNA probes).
Membranes were both exposed to a storage phosphor screen
(GE Healthcare) for further analysis using a phosphor imager
(Typhoon trio, GE Healthcare) and X-ray film.

Labeling of rRNA
Cells were seeded in 12-well plates at 5 3 106 cells per well
and pre-incubated for 45 min in methionine-free medium and
then incubated for 30 min with 50 mCi L-[methyl3H] methionine.
Cells were then chased in nonradioactive medium containing
15 mg/mL methionine for 0, 30, 60, and 120 min, after which total
RNA was isolated using Trizol (Invitrogen) and label incorporation for each sample was measured by scintillation counting.
An equal number of counts were loaded in each lane of a
1.25% agarose–formaldehyde gel and then transferred to
Hybond-N+ (GE Healthcare). Membranes were exposed to Xray film.

Antibodies
Anti-peptide RPS rabbit antibodies were generated from purified
synthetic peptides obtained from Biomolecules Midwest,
Inc..Three versions of each peptide were synthesized (native,
N-terminal cysteine, and N-terminal long-chain-biotin) and
a KLH-peptide was used to immunize two rabbits with the
resulting antiserum purified over a peptide-affinity column (Idol
et al. 2007). The peptides corresponding to human RPS sequences
were:
K7IVKPNGEKPDEFESG22 (RPS7);
N74LIKVDDNKKLGEWV88 (RPS12);
A1EVEQKKKRTFRKFTY16 (RPS15);
T102SRKQRKERKNRMKKVRGT120 (RPS24); and
K33KWSKGKVRDKLNNLVLFD51 (RPS25).
Commercially available rabbit polyclonal antibodies against RPS6,
RPL7, and RPL26 (Bethyl Laboratories) and RPS16 (GeneTX,
Inc.) were obtained and used following the manufacturers’
protocols. Rabbit polyclonal anti-GAPDH (Abcam) was used as
a loading control.

Sucrose gradient centrifugation
Cells were washed in ice-cold PBS and incubated with 100 mg/mL
cycloheximide in PBS for 10 min at 4°C prior to lysis. All
subsequent steps were performed on ice. Cells were resuspended
in hypotonic buffer (1.5 mM KCl, 2.5 mM MgCl2, and 5.0 mM
Tris-Cl at pH 7.4) followed by the addition of 80 units of RNase
inhibitor (Invitrogen). Hypotonic lysis buffer (1.5 mM KCl, 2.5
mM MgCl2, and 5.0 mM Tris-Cl pH 7.4, 2% sodium deoxycholate, 2% Triton X-100, and 2.5 mM DTT) were added and cells
were gently homogenized with 10 strokes of a Dounce homogenizer. Cell lysates were centrifuged at 8000g for 10 min at 4°C and
the supernatant was adjusted to 2 mg/mL heparin. Lysates were
stored at 80°C. Linear 10%–45% sucrose gradients (80 mM
NaCl, 5 mM MgCl2, 20 mM Tris-Cl at pH 7.4, and 1 mM DTT)
were poured using a Gradient Master (BioComp). Gradients were
centrifuged at 38,000 rpm for 3 h at 4°C and analyzed with an
ISCO fractionator (ISCO).

siRNA
A 21-bp siRNA targeting RPS19 was synthesized, annealed,
and purified (Ambion): 59-GAUGGCGGCCGCAAACUGUCA-39
(sense) and 59-UCAGUUUGCGGCCGCCAUCTT-39 (antisense),
named RPS19 siRNA #2. One additional siRNA targeting RPS19
was obtained from Ambion (siRNA ID# 2801). The following
siRNAs were purchased from Ambion to target ribosomal proteins
of interest:
RPS6 (siRNA ID #45962);
RPS7 (siRNA ID #142206 and 142207);
RPS15 (siRNA ID #142212);
RPS17 (siRNA ID #142215);
RPS24 (siRNA ID #45965);
RPS25 (siRNA ID #14220);
RPS28 (siRNA ID #41629 and 284684);
RPL5 (siRNA ID #142169);
RPL7 (siRNA ID #142173);
RPL11 (siRNA ID #9352);
RPL14 (siRNA ID #13949);
RPL26 (siRNA ID #9179); andRPL35a (siRNA ID #45958).
Silencer negative control #1 (Ambion) was used as a negative
control, and Silencer GAPDH (Ambion) was used as a positive
control. Cells were transfected with siPORT NeoFX (Ambion)
according to manufacturer’s protocols using 30 nM siRNA per
well.

Western blots
Total cell extracts were made using Cellytic Reagent
(Sigma) supplemented with a protease inhibitor cocktail (Roche),
and protein concentration was determined by a modified
Bradford assay (Bio-Rad). Proteins were separated on a 15%
SDS-PAGE gel and transferred to Hybond nitrocellulose
(GE Healthcare). Membranes were blocked overnight at 4°C
in Odyssey blocking buffer (LI-COR). Membranes were incubated
for 1 h at room temperature with primary antibodies in Odyssey
blocking buffer containing 0.05% Tween-20, and washed
three times with PBST. The secondary antibody, either goat
anti-rabbit IRDYE 680 (LI-COR) or goat anti-mouse IRDYE
680 (LI-COR), was added to Odyssey blocking buffer (LI-COR)
containing 0.05% Tween-20, and membranes were incubated for
1 h at room temperature. Membranes were washed twice with
PBST, rinsed with PBS, and signals were detected with the
Odyssey (LI-COR). All signal quantitation was performed with
the Odyssey (LI-COR).
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